Linkage Group | Total SSRs Screened | Number of Amplifiable Primer | Number of Polymorphic Primer | Amplification Ratio (%) | Polymorphic Ratio (%) |
---|---|---|---|---|---|
A01 | 110 | 98 | 19 | 89.09 | 17.27 |
A02 | 75 | 66 | 14 | 88.00 | 18.67 |
A03 | 128 | 121 | 23 | 94.53 | 17.97 |
A04 | 100 | 88 | 7 | 88.00 | 7.00 |
A05 | 89 | 81 | 9 | 91.01 | 10.11 |
A06 | 98 | 92 | 14 | 93.88 | 14.29 |
A07 | 62 | 54 | 15 | 87.10 | 24.19 |
A08 | 102 | 93 | 3 | 91.18 | 2.94 |
A09 | 91 | 82 | 20 | 90.11 | 21.98 |
A10 | 84 | 77 | 6 | 91.67 | 7.14 |
B01 | 99 | 89 | 20 | 89.90 | 20.20 |
B02 | 72 | 64 | 19 | 88.89 | 26.39 |
B03 | 95 | 89 | 8 | 93.68 | 8.42 |
B04 | 97 | 90 | 7 | 92.78 | 7.22 |
B05 | 76 | 72 | 8 | 94.74 | 10.53 |
B06 | 82 | 78 | 10 | 95.12 | 12.20 |
B07 | 80 | 72 | 13 | 90.00 | 16.25 |
B08 | 82 | 75 | 6 | 91.46 | 7.32 |
B09 | 75 | 66 | 15 | 88.00 | 20.00 |
B10 | 71 | 69 | 11 | 97.18 | 15.49 |
No linkage group information | 663 | 606 | 82 | 91.40 | 12.37 |
Total | 2431 | 2221 | 329 | 91.36 | 13.53 |